Defense Advanced Research Projects AgencyTagged Content List

Harness Biological Systems

Leveraging genetic technologies to engineer synthetic or natural organisms

Showing 37 results for Bio-systems RSS
February 21, 2017 ,
Webcast
The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) is sponsoring a Proposers Day to provide information to potential proposers on the objectives of a Broad Agency Announcement (BAA) for the RadioBio program.
September 30, 2016,
United States Institute of Peace
DARPA’s Biological Technologies Office (BTO) is hosting a Proposers Day to provide information to potential proposers on the objectives of the upcoming Safe Genes program. The program aims to help unlock the potential of advanced gene editing technologies by developing a set of biosafety and biosecurity tools to address potential risks of this rapidly advancing field.
August 29, 2017,
Webcast
The Defense Advanced Research Projects Agency (DARPA) Defense Sciences Office (DSO) is sponsoring a Proposers Day webcast to provide information to potential proposers on the objectives of an anticipated Research Announcement (RA) for the Young Faculty Award (YFA) program.
The BioFuels program seeks to develop renewable jet fuel (JP-8) for military aviation that meets or exceeds JP-8 performance metrics to help reduce the military’s dependence on traditional petroleum-derived fuels. These renewable fuels are derived from cellulosic materials and algal species that don’t compete with consumable food crops. The cellulosic material conversion process aims to demonstrate technology to enable 50% energy conversion efficiency in the conversion of cellulosic material feedstock to JP-8.
The Biological Robustness in Complex Settings (BRICS) program seeks to develop the fundamental understanding and component technologies needed to engineer biosystems that function reliably in changing environments. A long-term goal is to enable the safe transition of synthetic biological systems from well-defined laboratory environments into more complex settings where they can achieve greater biomedical, industrial, and strategic potential.